Aben Minerals
OTCMKTS:ABNAFAben Minerals Ltd. engages in the acquisition and exploration of mineral properties primarily in British Columbia, Saskatchewan, and Yukon, Canada. The company primarily explores for gold and graphite deposits. Its flagship project is the Forrest Kerr Gold project that covers an area of 23,397 hectares located in northwestern British Columbia. The company was formerly known as Aben Resources Ltd. and changed its name to Aben Minerals Ltd. in February 2023. Aben Minerals Ltd. was incorporated in 1960 and is headquartered in Vancouver, Canada.
Toubani Resources
OTCMKTS:AGGFFToubani Resources Inc. engages in the exploration and development of gold properties in West Africa. It focuses on the Kobada Gold project located in Southern Mali. The company was formerly known as African Gold Group, Inc. and changed its name to Toubani Resources Inc. in June 2022. Toubani Resources Inc. was incorporated in 2002 and is headquartered in Toronto, Canada.
Alacer Gold
OTCMKTS:ALIAFAlacer Gold Corp. engages in the mining, development, and exploration of mineral deposits in Turkey. It primarily holds an 80% interest in the Ãöpler gold mine that is located in the Erzincan Province, east-central Turkey. The company was incorporated in 1993 and is based in Denver, Colorado.
Pharmaceutical Resources
NYSE:PRXPar Pharmaceutical Companies, Inc. is a holding company that, principally through its wholly owned operating subsidiary, Par Pharmaceutical, Inc., is in the business of developing, licensing, manufacturing, marketing and distributing generic and branded drugs in the United States. The Company operates primarily in the United States as two business segments: Par Pharmaceutical (Par), its generic products division, and Strativa Pharmaceuticals (Strativa), its branded products division. In February 17, 2012, the Company acquired Edict Pharmaceuticals Private Limited. On November 17, 2011, it acquired Anchen Incorporated and its subsidiary, Anchen Pharmaceuticals, Inc. In October 2011, it acquired rights to three products from Teva Pharmaceuticals in connection with Teva's acquisition of Cephalon. In September 2012, certain affiliates of TPG acquired the Company.